These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4711734)

  • 1. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
    Aurelian L; Schumann B; Marcus RL; Davis HJ
    Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
    Kawana T; Sakamoto S; Kasamatsu T; Aurelian L
    Gan; 1978 Aug; 69(4):589-91. PubMed ID: 710808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to herpesvirus nonvirion antigens in squamous carcinomas.
    Hollinshead AC; Lee O; Chretien PB; Tarpley JL; Rawls WE; Adam E
    Science; 1973 Nov; 182(4113):713-5. PubMed ID: 4752210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens.
    Hollinshead AC; Tarro G
    Science; 1973 Feb; 179(4074):698-700. PubMed ID: 4734354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L; Kessler II; Rosenshein NB; Barbour G
    Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
    Hollinshead A; Lee OB; McKelway W; Melnick JL; Rawls WE
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):688-93. PubMed ID: 4564620
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria.
    Adelusi B; Osunkoya BO; Fabiyi A
    Am J Obstet Gynecol; 1975 Dec; 123(7):758-61. PubMed ID: 1106197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to surface antigens of herpesvirus type 1- and type 2-infected cells among women with cervical cancer and control women.
    Smith JW; Lowry SP; Melnick JL; Rawls WE
    Infect Immun; 1972 Mar; 5(3):305-10. PubMed ID: 4344217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus type 2 isolated from cervical tumor cells grown in tissue culture.
    Aurelian L; Strandberg JD; Melendez LV; Johnson LA
    Science; 1971 Nov; 174(4010):704-7. PubMed ID: 5123419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen.
    Schneweis KE; Haag A; Lehmköster A; Koenig U
    IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to herpesviruses in patients with cervical cancer and controls.
    Muñoz N; de-Thé G; Aristizabal N; Yee C; Rabson A; Pearson G
    IARC Sci Publ (1971); 1975; (11 Pt 2):45-51. PubMed ID: 191382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
    Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
    Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    te Velde ER; Aurelian L
    Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.